Overview
Panitumumab (ABX-EGF) is a recombinant human IgG2 monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). This drug is an antineoplastic agent. Panitumumab was granted FDA approval on 27 September 2006.
Indication
美国FDA批准：用于野生型KRAS(外显子2)转移性结直肠癌(mCRC)患者的一线治疗。
Associated Conditions
- Metastatic Colorectal Cancer (CRC)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/05/31 | Phase 3 | Not yet recruiting | |||
2025/02/11 | Early Phase 1 | Recruiting | |||
2025/02/11 | Phase 2 | Recruiting | |||
2024/12/03 | Phase 2 | Recruiting | National Cancer Institute, Naples | ||
2024/07/19 | Phase 3 | Recruiting | National Cancer Institute, Naples | ||
2024/07/08 | Phase 3 | Recruiting | IFOM ETS - The AIRC Institute of Molecular Oncology | ||
2024/03/27 | Phase 2 | Recruiting | |||
2024/03/18 | Phase 2 | Recruiting | Matteo's Friends | ||
2024/02/20 | Phase 2 | Recruiting | Nicholas DeVito, MD | ||
2024/02/12 | Phase 3 | Recruiting |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 12/3/2007 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| Vectibix Concentrate for Solution for Infusion 100 mg/vial | SIN14498P | INFUSION, SOLUTION CONCENTRATE | 100 mg/vial | 1/27/2014 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| VECTIBIX panitumumab 400mg/20mL concentrated injection vial | 128332 | Medicine | A | 5/14/2008 | |
| VECTIBIX panitumumab 100mg/5mL concentrated injection vial | 128270 | Medicine | A | 5/14/2008 |
Help Us Improve
Your feedback helps us provide better drug information and insights.